Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-10, Stock:JNJ, The news for the past five days is as follows:
2020-01-03: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: After Lackluster 2019, Pfizer Stock Could Rebound in 2020.NEWS3: Pulmatrix Surges on License Agreement With Johnson & Johnson.NEWS4: Glaxo (GSK) Shares Continue to Witness Upside: Here's Why.NEWS5: 4 Reasons Why You Should Invest in J&J (JNJ) Stock in 2020.NEWS6: Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock.
2020-01-06: NEWS1: Johnson & Johnson Reportedly Settles California Talc Case Midtrial.NEWS2: New antibiotics struggle to generate sales, pharma companies hurt.NEWS3: Dow down 50 points on losses for Walt Disney, Johnson & Johnson stocks.NEWS4: AstraZeneca's Farxiga sNDA Gets Priority Review Status by FDA.NEWS5: Dr. Paul Janssen Award for Biomedical Research Issues 2020 Call for Nominations to Celebrate Champions of Science.
2020-01-07: NEWS1: Dow Jones Today: Middle East Focus Factors Into The Equation Again.NEWS2: Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability.NEWS3: JNJ Stock Is Technically Inside A Buy Zone — Is It Time To Buy Shares?.NEWS4: Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder.
2020-01-08: NEWS1: Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable.NEWS2: Pacira's (PCRX) Exparel Meets Key Goals in C-Section Study.NEWS3: This Medical Giant Tried To Break Out — Should You Buy ABT Stock Now?.NEWS4: 3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020.NEWS5: Cambridge startup bringing AI to drug development raises $60M.
2020-01-09: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: 4 Things to Pay Attention to at the J.P. Morgan Health-Care Conference Next Week.NEWS3: Johnson & Johnson spinout signs licensing, collaboration deal worth up to $1.4B.

Answer: Decrease